Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS).

NCT01242813 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

TNF-receptor Associated Periodic Syndromes (TRAPS)

Interventions

DRUG: ACZ885

Sponsor

Novartis Pharmaceuticals